All India Institute of Medical Sciences (AIIMS) chief Dr Randeep Guleria said that children are more likely to get their vaccines by September.
To which, he explained that it will be a significant move to break the chain of Covid-19 transmission.
In an interview to a news channel, NDTV Dr Guleria said the Zydus Cadila has already done the trials and they're waiting for the emergency authorisation.
Dr Randeep Guleria said "The Bharat Biotech's Covaxin trials should be over by August or September, and by that time we should get approval. Pfizer vaccine has been already approved by the FDA (US regulator - Food and Drug Administration)".
The AIIMS Chief added, "Hopefully, by September, we should start vaccinating children, and that will be a big boost as far as breaking the chain of transmission is concerned."
He also added that both Bharat Biotech and Zydus are important as they are not sure if they will get required numbers of Pfizer vaccine so it will be helpful have more than one vaccine for children by September.
For the present, the European Medicines Agency has recommended authorising Moderna's covid vaccine for children age group 12 to 17 the the first time the shot has been authorized children.
Dr Randeep Guleria said, "I personally feel, in a graded manner, physical classes should start. A lot of children who don't have access to online classes are suffering."
The AIIMS chief further added that India can hopefully reopens its schools by the end of this year as children get vaccinated.
The total number of Covid-19 vaccine doses given so far in the country has reached over 42 crore. While the government hopes to vaccinate all the people above 18 years of age by the end of this year.
Although, the country is yet to clear a Covid-19 vaccine for children amidst growing concern of a possible third wave of the contagious virus affecting them.